Amsterdam, Noord-Holland, The NetherlandsFounded 1998319+ employeesQURE
$1.3B raisedIPO· last: post ipo equity (Sep 2025)· 9 rounds
Backed by(4 investors)
4 layoff events · Last: Oct 2024
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.
